EN DE

Savencia SA (SAVE) Fair Value & Analysis

Consumer Defensive · FR · Market cap €823M

SS Savencia SA SAVE · PA
Price€63.60
Fair Value€121.55
Upside+91.1%
Quality52/100
Watch Savencia SA for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 1.1% net margin
Low debt · generates free cash flow
2.21% dividend yield
Mixed vs. peers (7/15)
Narrow moat 32/100
Evidence: Medium Range €89.67 – €151.94 Share as image

Fair value as of: Jul 18, 2026

From 24 valuation models · updated 20 days ago

Share price −3.9% over the past month.

A solid business, screening 91% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (€89.67). The market is more pessimistic than our downside scenario.
  • Solid quality (52/100) at a price below fair value, the discount is the argument here, not the business quality.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

€74.20 €45.92 Fair Value €121.55 Jun 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.

How to read this chart

60‑month range €45.92 – €74.20 · fair‑value band €89.67 – €151.94 · the €63.60 price screens below the €121.55 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Savencia SA (SAVE) currently trades at €63.60, while our model-based Fair Value estimate is €121.55, implying the stock looks roughly 91.1% undervalued today. We read business quality at 52/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.

Over the trailing twelve months, Savencia SA generated revenue of €7.0B at a net margin of 1.1%. Revenue declined 5.3% year over year. It earns a return on equity of 4.6%. Net debt stands at €713M. Fundamentals as of Jul 18, 2026

Our scenario range runs from €89.67 (bear case) to €151.94 (bull case); at €63.60, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 15% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 91%, SAVE screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF €64.19 €76.80 €91.66 80
Residual Income €92.65 €90.66 €77.85 76
ROIC Compounder €92.57 €102.07 €109.99 72
All 24 models by family
DCF Models
FCF DCF €63.46 €77.27 €94.26 38
Owner Earnings €40.76 €46.83 €54.31 31
5Y Revenue Exit €102.05 €151.31 €212.48 39
5Y EBITDA Exit €181.10 €291.17 €414.87 41
5Y P/E Exit €83.93 €119.26 €154.32 38
10Y Revenue Exit €82.35 €120.46 €168.20 36
10Y EBITDA Exit €130.18 €206.59 €302.26 37
10Y P/E Exit €74.75 €100.72 €129.67 35
Earnings-Based
Graham-Dodd €39.36 €89.99 €115.37 54
PEG = 1.0 €14.99 €21.42 €27.84 46
EPV €92.57 €102.07 €109.99 59
Dividend Discount
Gordon GGM €16.57 €25.13 €33.41 70
DDM Multi-Stage €16.57 €22.95 €29.13 61
Multiples
P/E Multiple €86.82 €115.76 €144.70 63
P/S Multiple €73.80 €98.40 €123.00 58
P/B Multiple €73.80 €98.40 €123.00 55
EV/EBIT €192.46 €248.98 €305.51 53
EV/EBITDA €300.90 €393.56 €486.23 54
EV/Revenue €137.20 €186.18 €235.17 43
Asset-Based
NCAV (Graham) €65.22 €87.39 €130.44 50
Growth DCF
Growth DCF €64.19 €76.80 €91.66 80
Economic Profit
Residual Income €92.65 €90.66 €77.85 76
ROIC Compounder €92.57 €102.07 €109.99 72
Growth Earnings
Growth-Adj P/E €65.42 €93.46 €121.49 68

Widest divergence: DCF Models (€119.26) versus Dividend Discount (€22.95). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) €7.0B
Revenue growth (YoY) -5.3%
Net margin 1.1%
Return on equity 4.6%
Free cash flow €59.4M FY2025
P/E ratio 11.1
More key figures
Operating margin 3.0%
EPS (TTM) €5.73
Dividend yield 2.2%
EPS growth (YoY) -23.8%
Net debt €713M FY2025

Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 52/100

Of which business quality 50 · Market factors (momentum, volatility) 57

Profitability 52
Margins and returns on capital today
Quality Growth 38
Are margins and returns improving?
Cashflow 37
Earnings quality: real cash, not paper profit
Fin. Strength 46
Balance sheet, leverage, solvency risk
Investment 90
Disciplined investing over empire-building
Low Volatility 89
Calm price path (market factor)
Momentum 46
Price trend over the last 3–12 months (market factor)
52W Momentum 40
Distance to the 52-week high (market factor)
Net Issuance 52
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Savencia SA produces, distributes, and markets dairy and cheese products in France, the Rest of Europe, and internationally. The company offers cheese, butter, creams, and dairy ingredients and nutritional solutions for the retail market and food services market.

Full company description

Savencia SA produces, distributes, and markets dairy and cheese products in France, the Rest of Europe, and internationally. The company offers cheese, butter, creams, and dairy ingredients and nutritional solutions for the retail market and food services market. It offers its products under the Caprice des Dieux, Saint Albray, Le Rustique, C"ur de Lion, blue chesses, such as Saint Agur, Bresse Bleu, and PDO Roquefort Papillon; fresh cheeses, such as St-Morêt, Tartare, Carré Frais, Apérivrais; goat cheese, including Chavroux, Saint-Loup, RichesMonts raclette, Géramont, Saint Albray, Fol Epi, Bresso, Milkana, Brunch, Île-de-France, Milkaut, Santa Rosa, Delaco, Kral Syru, Lucina, Medve, Alouette, Rogue Creamery, Polenghi, Corman, and Elle & Vire brands. The company was formerly known as Bongrain SA and changed its name to Savencia SA in April 2015. Savencia SA was founded in 1956 and is headquartered in Viroflay, France. Savencia SA is a subsidiary of Savencia Holding.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Savencia SA reported revenue of €7.0B in FY2025 versus €5.6B in FY2021, a compound +5.5%/yr. Reported net income was €74.7M in FY2025, compounding −2.6%/yr from FY2021.

Growth Quality 61/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
€7.0B
Latest YoY
−2.6%
Avg. growth/yr (3Y)
+2.0%
Avg. growth/yr (5Y)
+6.2%
Avg. growth/yr (23Y)
+2.5%
Revenue +5.5%/yr
FY21 €5.6B
FY22 €6.6B
FY23 €6.8B
FY24 €7.1B
FY25 €7.0B
Net income −2.6%/yr
FY21 €82.9M
FY22 €68.0M
FY23 €96.5M
FY24 €107M
FY25 €74.7M

Watch SAVE: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Savencia SA Fair Value". https://www.fairvalue-calculator.com/stock/SAVE

Peer Group

Packaged Foods · 650 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 52 · Above median
Fair Value upside +91% · Top 25%
Return on equity (TTM) 5% · Below median
Return on assets 3% · Below median
Net margin (TTM) 1% · Below median
Operating margin (TTM) 3% · Below median
Revenue growth -5% · Bottom 25%
Dividend yield (TTM) 2.2% · Below median
Debt / equity 0.14× · Higher than median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 11.1× · Cheaper than 75% of peers
P/B 0.56× · Cheaper than 75% of peers
P/S (TTM) 0.14× · Cheaper than 75% of peers
P/FCF 16.0× · Pricier than 75% of peers
EV/EBITDA 1.7× · Cheaper than 75% of peers
PEG 0.32× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 30
FUTURE 0 · sector 20
PAST 18 · sector 27
HEALTH 93 · sector 96
DIVIDEND 44 · sector 47

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare Savencia SA with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Savencia SA (SAVE) overvalued or undervalued?
As of Jul 18, 2026, our model estimates a fair value of €121.55 versus a price of €63.60, about +91% (undervalued).
What is the fair value of SAVE?
Our model-based fair value for Savencia SA is €121.55 (as of Jul 18, 2026), built from audited fundamentals. The current price is €63.60.
What is the quality score of SAVE?
Savencia SA has a Quality Score of 52/100. It combines two groups: business quality (profitability, growth, cash flow, balance-sheet strength) and market factors (price momentum, distance to the 52-week high, volatility). Both subtotals are shown separately in the detail view.
What is the revenue of Savencia SA (SAVE)?
Savencia SA reported trailing-twelve-month revenue of about €7.0B (latest available figure, as of Jul 18, 2026).
What is the net profit margin of SAVE?
The net profit margin of Savencia SA is about 1.1%, meaning it keeps roughly 1.1% of revenue as net income. Based on the latest reported figures.
Does Savencia SA pay a dividend?
Savencia SA currently shows a dividend yield of about 1.97% relative to its recent price (as of Jul 18, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Savencia SA and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.